INTRODUCTION
The hematopoietic system sustains life through an almost limitless production of blood cells and resistance to infection. The generation of all blood cells originates in the embryonic tissue called aorta-gonad-mesonephros (AGM) 1, 2 . At around 12-15 days post coitum (dpc) of human embryos, a subset of endothelial cells called hemogenic endothelium (HE) in the AGM are specified to hematopoietic progenitor cells (HPCs) through endothelial to hematopoietic transition (EHT) 2 .
Capturing the precise mechanisms of human hematopoietic development, especially EHT process, will benefit efforts to generate blood cells in vitro for cell therapy, drug screening and disease modeling. [3] [4] [5] . Herein we propose a novel method to model human hematopoietic development in an organ-on-a-chip system [6] [7] [8] [9] [10] [11] . We developed a microfluidic AGM-on-a-chip which resembles key features of the cellular components of human AGM, including the HE, mesenchymal stroma (MS) and endothelial cells (ECs) 2 . We previously isolated a MS cell line from murine AGM that supports EHT in vitro (AGMS-3) 12 , which we use in the current study to recapitulate mesenchymal stroma in the AGM. We also used human umbilical vein endothelial cells (HUVECs) as a platform of ECs because they have the capacity to support hematopoiesis in vitro 13 and are easy to handle. We demonstrate that the AGM-chip efficiently induces EHT from human pluripotent stem cells (hPSCs) compared with regular suspension culture, providing a robust generation of human blood cells. Of note, the presence of both MS cells and ECs renders EHT with functional HPCs in vitro. We propose our AGM-chip as a novel platform to study the cellular and molecular mechanisms of human hematopoietic development.
RESULTS
The AGM-chip is biomimetic both in terms of structure and cellular interactions during Moreover, CFU capacity of the AGM-chip was relatively higher than that of suspension culture at both 1-week (p=0.051) and 2-week (p=0.08) of culture in the presence of feeder cells (Fig. 3C ).
These data demonstrate the advantage of our AGM-chip in producing HPCs over suspension culture, indicating microenvironmental cues play an important role in the induction of EHT. To assess the EHT capacity of an intact AGM-chip, we harvested cells from the outflow of the device by perfusing culture medium using a ring pump at a flow rate of 20 uL min -1 ( fig. 4A ). We found that around 1.5% of the outlet cells were CD34+CD45+ HPCs and confirmed their colony-forming capacity (fig. 4B-C). These data demonstrate that the AGM-chip produces HPCs through EHT.
DISCUSSION
In this paper, we present an in vitro AGM-on-a-chip platform as biomimetic AGM, which is where blood cells emerge during development 15 . We demonstrated that perfusion culture in the AGMchip yields more EHT than suspension cell culture indicated by the presence of HPCs. Finally, we established that feeder cells support EHT. We expect the AGM-chip could be a powerful experimental tool with which end users can assess the effects of target signaling, small molecules and genetic interventions in human developmental hematopoiesis.
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METHODS

Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Yu-suke Torisawa (torisawa.yusuke.6z@kyoto-u.ac.jp).
Cell lines
All the experiments of this study were performed with 409B2 iPSCs or CBA11 iPSCs (Ohta, 2019).
HUVECs were either purchased from Angio-Proteomie (GFP-HUVEC, cAP-01001GFP) or Lonza (issue Acquisition Number: 29000). AGMS-3 was isolated and cultured as described previously (Xu 1998 ).
hPSC culture
The maintenance of hPSCs was done using iMatrix-511 (Matrixome) in mTeSR1 media (STEMCELL Technologies). Media were changed every other day, and the cells were passaged as single cells every 7 days using TrypLE Express (Life technologies).
Cell Culture
Green fluorescent protein-expressing and red fluorescent protein-expressing HUVECs (GFP-HUVECs and mCherry-HUVECs, respectively, Angio-Proteomie) were cultured in endothelial cell growth medium-2 (EGM-2, Lonza). All the experiments were conducted using HUVECs of passage 7 or lower. AGMS-3 cells were cultured in alpha-MEM (Thermo Fischer Scientific) containing 15% FBS, 100 U mL -1 penicillin, and 100 U mL -1 streptomycin.
Hemogenic endothelial differentiation hPSC spheroids were formed as described previously (JoVE, 2019), suspended in mTeSR1 (StemCell Technologies) containing 1.25 μg/mL iMatrix-511 (Matrixome), and plated onto noncoated culture plates. After three days, the medium was replaced with Essential 8 (Life technologies) containing 4 μM CHIR99021 (WAKO), 80 ng/mL BMP4 (R&D systems), and 80 ng/mL VEGF (R&D systems). After two more days, the medium was replaced with Day 2 differentiation medium: Essential 6 with 1 µM SB431542, 80 ng/mL VEGF, and 100 ng/mL Stem cell factor (SCF). Finally, two days later, the cells were harvested with TrypLE express, and CD34+ cells were isolated by MACS.
Colony forming unit assay
After 1 or 2 weeks of culture, CD34+ cells were sorted by MACS and cultured at a concentration of 1×10 3 cells/mL in one well of a 6-well plate (#1008; Becton-Dickinson) with 1 mL/well MethoCult GF+ semisolid medium (#4435; STEMCELL Technologies). Colonies were counted after 14 days of incubation using an inverted microscope by three individuals. 
Microfluidic Cell Culture
The microfluidic device was sterilized in UV light for 2 hours. Following the sterilization, the semipermeable membrane of the device was coated with fibronectin (#33016015, Gibco) by incubating the microchannels with a fibronectin solution (100 ug mL -1 in PBS) at room temperature for 2 hours. The channels were then rinsed with culture medium prior to cell seeding. A suspension of HUVECs (5 x 10 4 cells per 10 uL) was introduced into the bottom channel, and then the device was inverted and incubated at 37 o C for 1 hour to allow the cells to adhere onto the bottom side of the membrane. Once cellular attachment was confirmed, the device was flipped back, and the microchannels were filled with culture medium (EGM-2). After 1 day in culture, a suspension of AGMS-3 cells (2 x 10 4 cells per 10 uL) was introduced into the top channel. After incubation at 37 o C for 1 hour, culture medium (alpha-MEM) was introduced into the top channel and incubated at 37 o C for 1 day to form layers of endothelium and mesenchymal stroma.
Subsequently, a suspension of HE cells (5 x 10 4 cells per 10 uL) was introduced into the top channel and incubated at 37 o C for 2 hours to enable cell attachment. The reservoirs were filled with EHT medium (150 uL in each reservoir), and the device was put in an incubator (37 o C, 5% CO2). The device was cultured for up to 14 days with replacement of the culture medium every 2 or 3 days. 
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